BOIRON : ACTIVITY IN 2015

le
0

(Unaudited data)


· Cumulative activity as of the end of december 2015

thousands of euros 2014 2015 Variation at current exchange rates Variation at constant exchange rates
France 343,891 361,765 +5.2% +5.2%
Europe (excluding France) 198,918 167,714 -15.7% -11.9%
North America 52,813 63,858 +20.9% +3.8%
Other countries 14,126 14,466 +2.4% +5.7%
Group total 609,748 607,803 -0.3% -0.5%

 

thousands of euros 2014 2015 Variation at current exchange rates Variation at constant exchange rates
Non-proprietary Homeopathic Medicines 305,501 310,555 +1.7% +0.8%
OTC Specialties 303,549 296,954 -2.2% -1.7%
Other 698 294 -57.9% -37.7%
Group total 609,748 607,803 -0.3% -0.5%



· Quarterly activity in 2015 ( variation at current rate)

thousands of euros

1st quarter

2nd quarter

3rd quarter

4th quarter

2014

2015

Var. 15/14

2014

2015

Var. 15/14

2014

2015

Var. 15/14

2014

2015

Var. 15/14

France

82,749

89,584

+8.3%

74,269

76,864

+3.5%

92,466

97,767

+5.7%

94,407

97,550

+3.3%

Europe (excluding France)

39,967

40,657

+1.7%

33,570

29,943

-10.8%

62,758

50,614

-19.4%

62,623

46,500

-25.7%

North America

12,662

17,193

+35.8%

10,625

12,894

+21.4%

13,109

16,055

+22.5%

16,417

17,716

+7.9%

Other countries

4,831

4,622

-4.3%

2,943

3,816

+29.7%

3,779

3,594

-4.9%

2,573

2,434

-5.4%

Group total

140,209

152,056

+8.4%

121,407

123,517

+1.7%

172,112

168,030

-2.4%

176,020

164,200

-6.7%

 

thousands of euros

1st quarter

2nd quarter

3rd quarter

4th quarter

2014

2015

Var. 15/14

2014

2015

Var. 15/14

2014

2015

Var. 15/14

2014

2015

Var. 15/14

Non-proprietary Homeopathic Medicines

77,919

79,191

+1.6%

73,072

74,354

+1.8%

72,957

73,677

+1.0%

81,553

83,333

+2.2%

OTC Specialties

62,196

72,880

+17.2%

48,058

49,030

+2.0%

99,025

94,328

-4.7%

94,270

80,716

-14.4%

Other

94

-15

-

277

133

-52.0%

130

25

-80.8%

197

151

-23.4%

Group total

140,209

152,056

+8.4%

121,407

123,517

+1.7%

172,112

168,030

-2.4%

176,020

164,200

-6.7%



Highlights of the fourth quarter

Sales revenue of the fourth quarter 2015 was down by 6.7% (-6.4% at constant rate). Such decrease mainly results from the situation in Russia. 

Thus, the 2015 operating income will be lower than in 2014.

On December 22, 2015, our company has set up a new subsidiary in India and thus confirms its involvement in the development of homeopathy in the world.


Our next update: March 16, 2016, after the close of the stock market, publication of 2015 results.
Person responsible for financial information: Christian Boiron
Contact for financial information: Véronique Bouscayrol
Investor relations: +33 (0) 4.78.45.63.43 - e-mail : boironfinances@boiron.fr
ISIN Code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA
The group's financial information is online at: www.boironfinance.com


Information réglementée
Communiqués au titre de l'obligation d'information permanente :
- Communiqué sur comptes, résultats, chiffres d'affaires
Full and original press release in PDF:
http://www.actusnews.com/documents_communiques/ACTUS-0-42839-BOI-210116-CA-15-GB.pdf

Si le fichier PDF ne s'affiche pas ou pour le télécharger, cliquez ici.

Pour consulter le fichier PDF en intégralité, cliquez ici.

Pour visualiser les documents au format PDF, vous pouvez télécharger gratuitement Acrobat Reader XI.


Valeur associée
  Libellé Bourse Dernier Var. Vol.
Vous devez être membre pour ajouter des commentaires.
Devenez membre, ou connectez-vous.
Aucun commentaire n'est disponible pour l'instant